MEDITULIP
Seoul, South Korea · Founded 2015
- Headquarters
- Seoul
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- meditulip.co.kr
About
MEDITULIP is a South Korean medical device company specializing in minimally invasive surgical tools, including its patented Asymmetric Endoscopic Linear Stapler and the TULIP PORT implantable chemoport. The company's Asymmetric Linear Stapler enables pathological confirmation of cancer cell presence at the resection margin during surgery, introducing a new paradigm in oncological radicality. MEDITULIP holds ISO 13485:2016 certification and received regulatory approval from South Korea's Ministry of Food and Drug Safety. The company won the 2024 EACTS Techno-College Innovation Award and is backed by Genaxis.
Summary
MEDITULIP is a Biotech company based in Seoul, South Korea, founded in 2015.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/meditulip"><img src="https://indexed.vc/api/badge/company/meditulip" alt="MEDITULIP on Indexed.vc" width="260" height="76" /></a>